Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574273 · ClinicalTrials.gov registry record · NA
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
A NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT02574273: Completed NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Weill Medical College of Cornell University.
NCT02574273 is a NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD) that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 106 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574273, a NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD), has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont \& Sofronoff, 2008; Tan, Mazzucchelli \& Beaumont, submitted), school-(Beaumont, Rotolone \& Sofronoff, in press; Einfeld et al., submitted) and remote Skype/telephone-assisted delivery contexts (Sofronoff, Silva \& Beaumont, in press).The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder.
Primary Outcome
Change in anxiety will be measured at these time points.
Conditions Studied
Interventions
- BEHAVIORAL Secret Agent Society (SAS) Program
- OTHER Waitlist Group / Treatment As Usual
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02574273 record still lists
NCT02574273 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Secret Agent Society (SAS) Program is the first listed.
NCT02574273 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02574273 about?
NCT02574273 is a clinical study titled "Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)". Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont \& Sofronoff, 2008; Tan, Mazzucchelli \& Beaumont, submitted), school-(Beaumo...
What is the current status of trial NCT02574273?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2015-10. Estimated completion is 2018-12.
What conditions does trial NCT02574273 study?
This clinical trial studies the following conditions: Anxiety, Attention Deficit Hyperactivity Disorder (ADHD), Autistic Spectrum Disorder (ASD).
What interventions are being tested in trial NCT02574273?
The interventions under investigation include: Secret Agent Society (SAS) Program (BEHAVIORAL), Waitlist Group / Treatment As Usual (OTHER).
Who is sponsoring clinical trial NCT02574273?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02574273 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02574273's enrollment target sits among peer trials
106 158th of 364 higher than 205 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia